
Mary M. Lyons
Examiner (ID: 1163, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1653, 1645 |
| Total Applications | 662 |
| Issued Applications | 371 |
| Pending Applications | 93 |
| Abandoned Applications | 224 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15738489
[patent_doc_number] => 20200108132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => ANTI-MALARIA COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/589540
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16589540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/589540 | ANTI-MALARIA COMPOSITIONS AND METHODS | Sep 30, 2019 | Abandoned |
Array
(
[id] => 15988773
[patent_doc_number] => 20200170257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => MICROORGANISMS FOR PLANT PATHOGEN INHIBITION
[patent_app_type] => utility
[patent_app_number] => 16/585023
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585023 | Microorganisms for plant pathogen inhibition | Sep 26, 2019 | Issued |
Array
(
[id] => 15683689
[patent_doc_number] => 20200096508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => TUBE-PRECIPITIN ANTIGEN OF COCCIDIOIDES POSADASH
[patent_app_type] => utility
[patent_app_number] => 16/583486
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16583486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/583486 | Tube-precipitin antigen of coccidioides posadash | Sep 25, 2019 | Issued |
Array
(
[id] => 16253852
[patent_doc_number] => 20200263226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => Method for Rapidly Determining Sterilization, Deimmunization, and/or Disinfection
[patent_app_type] => utility
[patent_app_number] => 16/583515
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16583515
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/583515 | Method for Rapidly Determining Sterilization, Deimmunization, and/or Disinfection | Sep 25, 2019 | Abandoned |
Array
(
[id] => 17266447
[patent_doc_number] => 11191851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Anti-C3d antibody conjugates and methods of detecting complement activation
[patent_app_type] => utility
[patent_app_number] => 16/572260
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 52
[patent_no_of_words] => 70888
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572260 | Anti-C3d antibody conjugates and methods of detecting complement activation | Sep 15, 2019 | Issued |
Array
(
[id] => 17043740
[patent_doc_number] => 11096899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Bacterial membrane nanoparticles as an immunotherapy system for cancer treatment
[patent_app_type] => utility
[patent_app_number] => 16/562133
[patent_app_country] => US
[patent_app_date] => 2019-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 8789
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/562133 | Bacterial membrane nanoparticles as an immunotherapy system for cancer treatment | Sep 4, 2019 | Issued |
Array
(
[id] => 16697896
[patent_doc_number] => 10948487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Peptides, devices, and methods for the detection of Ehrlichia antibodies
[patent_app_type] => utility
[patent_app_number] => 16/552381
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24847
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 609
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16552381
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/552381 | Peptides, devices, and methods for the detection of Ehrlichia antibodies | Aug 26, 2019 | Issued |
Array
(
[id] => 15559889
[patent_doc_number] => 20200064356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHOD FOR DIAGNOSING AND TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/543741
[patent_app_country] => US
[patent_app_date] => 2019-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16543741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/543741 | METHOD FOR DIAGNOSING AND TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER | Aug 18, 2019 | Abandoned |
Array
(
[id] => 17525748
[patent_doc_number] => 11298414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Cellular adjuvants for viral infection
[patent_app_type] => utility
[patent_app_number] => 16/536962
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 12
[patent_no_of_words] => 8176
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/536962 | Cellular adjuvants for viral infection | Aug 8, 2019 | Issued |
Array
(
[id] => 16656080
[patent_doc_number] => 20210052716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => A novel K-serotype Vibrio parahaemolyticus and application
[patent_app_type] => utility
[patent_app_number] => 16/771693
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771693 | Method for preparing a K serum with a vibrio parahaemolyticus as an antigen | Jul 29, 2019 | Issued |
Array
(
[id] => 15432423
[patent_doc_number] => 20200030394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING THE EYE
[patent_app_type] => utility
[patent_app_number] => 16/519149
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519149
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519149 | Compositions and methods for treating the eye | Jul 22, 2019 | Issued |
Array
(
[id] => 15408623
[patent_doc_number] => 20200024633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => ANTIMICROBIAL SUSCEPTIBILITY TESTING AND MICROBIAL IDENTIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/516184
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/516184 | Antimicrobial susceptibility testing and microbial identification | Jul 17, 2019 | Issued |
Array
(
[id] => 16695513
[patent_doc_number] => 10946082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Immunomodulatory compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/511847
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 30
[patent_no_of_words] => 51676
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511847
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511847 | Immunomodulatory compositions and methods of use thereof | Jul 14, 2019 | Issued |
Array
(
[id] => 15931045
[patent_doc_number] => 20200157156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => GRATELOUPIA CHIANGII-DERIVED LECTIN AND LECTIN GENE CODING FOR THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/509513
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16509513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/509513 | GRATELOUPIA CHIANGII-DERIVED LECTIN AND LECTIN GENE CODING FOR THE SAME | Jul 11, 2019 | Abandoned |
Array
(
[id] => 16885766
[patent_doc_number] => 20210171961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/255270
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255270 | SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM | Jul 2, 2019 | Pending |
Array
(
[id] => 16549750
[patent_doc_number] => 10882899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Anti
[patent_app_type] => utility
[patent_app_number] => 16/503211
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 13
[patent_no_of_words] => 13231
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16503211
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/503211 | Anti | Jul 2, 2019 | Issued |
Array
(
[id] => 14833379
[patent_doc_number] => 20190275090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/423487
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423487 | Treatment of | May 27, 2019 | Issued |
Array
(
[id] => 16651222
[patent_doc_number] => 10928394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Rapid test for lyme bacteria
[patent_app_type] => utility
[patent_app_number] => 16/422802
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5579
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422802 | Rapid test for lyme bacteria | May 23, 2019 | Issued |
Array
(
[id] => 15117205
[patent_doc_number] => 20190345235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => Type III Secretion System Targeting Molecules
[patent_app_type] => utility
[patent_app_number] => 16/419677
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419677 | Type III secretion system targeting molecules | May 21, 2019 | Issued |
Array
(
[id] => 16468494
[patent_doc_number] => 20200370031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => MULTILAYER NANO-CELL CONTAINING BIOMOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/419508
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419508 | Multilayer nano-cell containing biomolecules | May 21, 2019 | Issued |